IRIS
MONDELLI, MARIO UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.265
EU - Europa 4.606
AS - Asia 2.960
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 5
SA - Sud America 1
Totale 13.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.196
CN - Cina 2.883
IE - Irlanda 1.377
UA - Ucraina 865
FI - Finlandia 621
DE - Germania 533
IT - Italia 459
SE - Svezia 360
GB - Regno Unito 206
FR - Francia 126
CA - Canada 66
IN - India 26
VN - Vietnam 22
BE - Belgio 15
IR - Iran 13
NL - Olanda 13
RU - Federazione Russa 11
AU - Australia 10
CH - Svizzera 6
EU - Europa 6
SG - Singapore 6
MU - Mauritius 4
A2 - ???statistics.table.value.countryCode.A2??? 3
ES - Italia 3
HK - Hong Kong 3
LU - Lussemburgo 3
MX - Messico 3
GR - Grecia 2
ID - Indonesia 2
JP - Giappone 2
NZ - Nuova Zelanda 2
AT - Austria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
RS - Serbia 1
TR - Turchia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 13.858
Salva come PNG Salva come JPEG
Città #
Chandler 1.432
Dublin 1.373
Jacksonville 1.191
Nanjing 902
Ashburn 679
Nanchang 380
Princeton 321
Lawrence 288
Wilmington 271
Shenyang 251
Hebei 237
Jiaxing 218
Changsha 216
Tianjin 162
Beijing 160
Medford 158
Milan 143
Hangzhou 138
Helsinki 136
Boardman 134
Ann Arbor 99
Verona 68
New York 64
Shanghai 64
Woodbridge 60
Norwalk 56
Toronto 53
Pavia 50
Seattle 41
Fairfield 26
Des Moines 25
Los Angeles 23
Dong Ket 22
Jinan 21
Falls Church 20
Zhengzhou 20
Auburn Hills 19
Kunming 18
Brussels 15
Pune 15
Washington 14
Berlin 13
Ningbo 13
Trieste 13
Bergamo 12
Dearborn 12
Vicenza 11
Houston 9
Guangzhou 8
Lodi 8
San Jose 8
Taizhou 8
London 7
Cambridge 6
Changchun 6
Como 6
Rome 6
Singapore 6
Travaco Siccomario 6
Borås 5
Gunzenhausen 5
Modena 5
Orange 5
Zanjan 5
Carbonara al Ticino 4
Chicago 4
Cork 4
Dresden 4
Hefei 4
Lanzhou 4
Leawood 4
Motta Visconti 4
Novokuznetsk 4
Serra 4
Andover 3
Catania 3
Costa Mesa 3
Ferrara di Monte Baldo 3
Magenta 3
Naples 3
Saluzzo 3
Sydney 3
Tijuana 3
Turin 3
Aachen 2
Arlington 2
Athens 2
Bologna 2
Brembate di Sopra 2
Busto Arsizio 2
Canyon Country 2
Esch-sur-Alzette 2
Falkenstein 2
Fuzhou 2
Hong Kong 2
Kemerovo 2
Las Vegas 2
Melbourne 2
Ottawa 2
Rockville 2
Totale 9.868
Salva come PNG Salva come JPEG
Nome #
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma 248
Mapping the human genetic architecture of COVID-19 124
Hepatitis B virus structure and biology. 85
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 84
Does the immune response play a role in the pathogenesis of chronic liver disease? 82
A first update on mapping the human genetic architecture of COVID-19 79
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 75
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 73
NKG2D and its ligands: key to immunotherapy of liver cancer? 72
Recombinant human antibodies specific for hepatitis C virus proteins 71
ANTIBODY RESPONSES TO HEPATITIS C VIRUS HYPERVARIABLE REGION 1: EVIDENCE FOR CROSS-REACTIVITY AND IMMUNE-MEDIATED SEQUENCE VARIATION. 69
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 67
Detection of genomic and minus strand C virus RNA in the liver of chronic hepatitis C patients by strand-specific semi-quantitative RT-PCR 67
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 66
Acute hepatitis C: diagnosis and management. 66
Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. 66
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 65
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 65
Cytotoxic T cell in chronic non-A, non-B hepatitis 64
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 64
Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications 64
Characterization of monoclonal antibodies (mAb) from mice immunized with HCV hypervariable region 1 (HVR1) mimotopes. 64
B lymphocyte activation in chronic HCV infection: implications for autoimmune and lymphoproliferative disorders 64
A major conformational B cell epitope on the HCV NS3 region defined by a human monoclonal antibody 64
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 63
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 63
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 63
Enhanced NK cytolytic activity in chronic HCV infection 63
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 63
Mapping the human genetic architecture of COVID-19 63
Characterization of cryoglobulins from patients with type II mixed cryoglobulinaemia associated with HCV 62
Relationship between expression of HBV antigenes in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic HBV infection. 62
Identification of HCV core mimotopes: improved methods for the selection and use of diasease-related phage-displayed peptides 62
A human monoclonal antibody specific for a conserved epitope within the HCV protein 62
Autoimmune hepatitis in children and hepatitis C virus testing 62
PD-L1 negatively regulates CD4+CD25+Foxp3+ tregs by limiting STAT-5 phosphrylation in patients chronically infected with HCV 62
Mimotopes of the hypervariable region 1 of the hepatits C virus induce cross-reactive antibodies directed against discontinuous epitopes 61
Clinical significance of hepatitis C virus genotypes. 61
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 61
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C 61
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 61
Immunophatological aspects of liver cell injury in chronic hepatitis B virus infection 61
A survey of hepatitis C virus infection in haemodialysis patients over a 7-years follow-up. 61
Monitoring response to antiviral therapy in patients with chronic hepatitis C virus infection by a core antigen assay. 60
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 60
Mutations at position 385 within the hypervariable region 1 (HVR1) of the hepatitis C virus (HCV) are rare and not rescricted to patients with cryoglobulinemia 60
High prevalence of antibodies to hepatitis C virus in haemodialysis units using a 2nd generation assay 60
A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein 60
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 60
Defective cytotoxic function of intrahepatic natural killer cells in chronic hepatitis C virus infection 60
EASL Clinical Practice Guidelines: management of hepatitis C virus infection 60
Assessment of HCV RNA clearance under combination therapy for HCV genotype 1: performance of the transcription-mediated amplification (TMA) assay. 59
Natural killer activity in acute viral hepatitis 59
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T-cell lines 59
HCV viremia in hemodialysis patients 59
Adenoviral mediated expression of anti-HCV NS3 single-chain Fv (sFv) antibody reduces HCV RNA in infected hepatocytes 59
Subversion of CD8+ T cell differentiation in acute hepatitis C virus infection: the role of the virus. 58
Alfa-interferon enhances non-T cell cytotoxicity fo rautologous hepatocytes in acute and chronic HBV infection 58
Interferon-alpha enhances non-specific cytotoxicity for autologous hepatocytes in acute and chronic hepatitis B virus infection 58
Lymphocyte cytotoxycity to autologous hepatotytes in alfa1-antitrypsin deficiency. 58
Optimization for the detection of hepatitis C virus (HCV) antigens in the liver 58
Humoral immunity against the hypervariable regione 1 of the putative envelope glycoprotein (Gp70) in hepatitis C patients 58
NK cell phenotype and function are profoundly different in patients with chronic HBV and HCV infections 58
Who is more likely to respond to dual treatment with PEG-interferon and ribavirin for chronic hepatitis c? A gender-oriented analysis 58
SIGNIFICANCE OF THE IMMUNE RESPONSE TO A MAJOR, CONFORMATIONAL B CELL EPITOPE ON THE HEPATITIS C VIRUS NS3 REGION DEFINED BY A HUMAN MONOCLONAL ANTIBODY 58
Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes 58
Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. 58
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 58
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. 57
Hepatitis C is more severe in drug users with human immunodeficiency virus infection 57
Absence of antibodies to human immunodeficiency virus in long-term institutionalized psychiatric patients. 57
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 57
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection 57
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C 56
Hepatitis C virus infection among institutionalized psychiatric patients: a regression analysis of indicators of risk. 56
Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign? 56
Identification of an immunodominant B-cell epitope on the NS4 subregion of HCV defined by human monoclonal antibodies. 56
Natural killer cells in viral hepatitis: facts and controveries 56
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 56
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 56
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 55
Association between class II allelles and protection or susceptibility to chronic hepatitis C 55
Accuracy of the ElastPQ Technique for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C: a "Real Life" Single Center Study 55
High efficiency of transmission of hepatitis C virus among babies born to human immunodeficiency virus-negative women. 55
Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial. 55
Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts? 54
Mimotopes of the hypervariable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. 54
Multifaceted functions of B cells in chronic hepatitis C virus infection 54
Occult hepatitis B virus infection 54
Monoclonal antibodies defining the T-cell target antigens in acute and chronic HBV infection 54
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 54
A phase II, single arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 54
Linking viral infections to autoimmunity: B-cell activation in chronic hepatitis C. 54
Chronic hepatitis C (CH-C) genotype 1: an independent multicentre RCT comparing PEG-IFN alfa-2b 12kD plus ribavirin (RBV) and IFN alfa-2b and RBV in naive patients 54
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 54
Caratterizzazione delle IgG presenti nel crioprecipitato di pazienti con crioglobulinemia mista di tipo II associata ad infezione da HCV 54
Polymorphisms of microsomal epoxyde hydrolase gene and severity of HCV-related liver disease. 53
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 53
Production of anti-HCV by human B cell clones and their characterization 53
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 53
Totale 6.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 2 10
2019/20203.454 1.018 1.521 2 157 2 182 18 175 18 270 89 2
2020/20211.715 188 140 71 162 9 216 17 276 59 274 222 81
2021/20221.209 45 11 50 33 16 71 12 83 70 25 196 597
2022/20234.256 514 232 30 466 431 451 2 223 1.645 16 201 45
2023/20241.549 149 246 46 115 162 374 47 363 7 40 0 0
Totale 14.363